Company / R&D per Share
Rani Therapeutics Holdings, Inc. R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$937.00
FY2025
5-year range
$0.62 / $1553.58
FY2021-FY2025
Trend
-39.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1355.69 to $937.00 over the past 3 years.
Based on SEC 10-K filings.
937.00 in FY2025 with a 3-year CAGR of -11.6%.
Declined from $1355.69 to $937.00 over the past 3 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -11.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 39.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $937.00 | -39.7% |
| FY2024 | $1553.58 | +14.6% |
| FY2022 | $1355.69 | +219777.1% |
| FY2021 | $0.62 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026